Form 4 for TMDX TransMedics Group, Inc.
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0000899243-22-037661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-12-05 | 2022-12-01 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $2.21 | +11.1K | 11.1K | New | +$24.4K |
| D | 2022-12-05 | 2022-12-01 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.00 | -11.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | M | A | 11,051 | $2.21 | 11,051 | I By the Tamer Ibrahim Ahmed Khayal Trust | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-12-01 | M | D | 11,051 | $0.00 | 0 | D | $2.21 · — to 2027-06-22 | 11,051 Common Stock | (F2) The option is fully vested. |